IGHE and glioma: Recently, many studies demonstrated that Evo may be a potential therapeutic drug against other chronic diseases such as renal tubulo-interstitial fibrosis [14], atherogenesis [15], hypoxia [16], glioma [17], hypomotility disorders [9], and IgE-induced allergenic diseases, including atopic dermatitis and rhinitis [18].